About the Authors

Carl T. Gustafson

Gustafson.carl@mayo.edu

Affiliation Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Graduate School, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55902, United States of America

Felix Boakye-Agyeman

Affiliation Pharmacometrics Center, Duke Clinical Research Institute (DCRI), Durham, North Carolina 27705, United States of America

Cassandra L. Brinkman

Affiliation Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic Infectious Disease Research Laboratory, Mayo Clinic, Rochester, Minnesota 55902, United States of America

Joel M. Reid

Affiliation Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Graduate School, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55902, United States of America

Robin Patel

Affiliation Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic Infectious Disease Research Laboratory, Mayo Clinic, Rochester, Minnesota 55902, United States of America

Zeljko Bajzer

Affiliations Division of Biomathematics, Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55902, United States of America, Division of Biomathematics, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55902, United States of America

Mahrokh Dadsetan

Affiliation Division of Orthopaedic Research, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55902, United States of America

Michael J. Yaszemski

Affiliations Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Graduate School, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55902, United States of America, Division of Orthopaedic Research, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55902, United States of America

Competing Interests

The authors of this manuscript report the following competing interests: patent for "Photocrosslinkable oligo(poly (ethylene glycol) fumarate) hydrogels for cell and drug delivery." Inventors: Mahrokh Dadsetan, Michael Yaszemski, Lichun Lu. Filing Date: March 23, 2006. Patent number: US 8343527 B2. This competing interest affects co-authors MJY and MD. It does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: CTG FBA CLB JMR ZB MD MJY. Performed the experiments: CTG FBA CLB. Analyzed the data: CTG CLB ZB MD. Contributed reagents/materials/analysis tools: JMR RP ZB MJY. Wrote the paper: CTG FBA CLB JMR RP ZB MJY.